EUVIMEDEUVIMED entdecken
Crossref

Laminin Gamma 2 (LAMC2)-Targeting F(ab′) 2 for 89 Zr Immuno-PET Imaging of Human NSCLC Xenograft Models

RenCai Lu iD, JianFang Zhang, GuangFa Bao, YanYan Kong, DongDong Xv, ShaoBo Wang

Molecular Pharmaceutics · 06.07.2026 · 23 (7) · 3732-3742

DOI: 10.1021/acs.molpharmaceut.6c00200 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, online erschienen am 29.05.2026. Verfasst von RenCai Lu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, The First People's Hospital of Yunnan Province, the Affiliated Hospital of Kunming University of Science and Technolo…. Hauptthemen laut MEDLINE: Zirconium, Radioisotopes, Lung Neoplasms, Carcinoma, Non-Small-Cell Lung. Die Arbeit nennt 44 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Yunnan Talent Support Program, Open Research Project from the First People?s Hospital of Yunnan Province and Yunnan Clinical Research Center for Respiratory Disease.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ZirconiumRadioisotopesLung NeoplasmsCarcinoma, Non-Small-Cell LungLamininImmunoglobulin Fab FragmentsHumansAnimalsMiceTissue DistributionCell Line, TumorMice, NudePositron Emission Tomography Computed TomographyFemaleXenograft Model Antitumor AssaysPositron-Emission TomographyAntibodies, MonoclonalA549 CellsRadiopharmaceuticals

Stichwörter der Autor:innen

immuno-PETlaminin gamma 2 (LAMC2)radioimmunoconjugatezirconium-89

Substanzen

ZirconiumRadioisotopesZirconium-89LamininLAMC2 protein, humanImmunoglobulin Fab FragmentsAntibodies, MonoclonalRadiopharmaceuticals

Autor:innen und Institutionen

  • Department of Nuclear Medicine, The First People's Hospital of Yunnan Province, the Affiliated Hospital of Kunming University of Science and Technology, Kunming 650032, China.
  • Department of Nuclear Medicine and PET Center, Huashan Hospital, Fudan University, Shanghai 200040, China.

ORCID-Profile: RenCai Lu

Förderung

  • National Natural Science Foundation of China
  • Yunnan Talent Support Program
  • Open Research Project from the First People?s Hospital of Yunnan Province and Yunnan Clinical Research Center for Respiratory Disease
  • Kunming University of Science and Technology and the First People?s Hospital of Yunnan Province Joint Special Project on Medical Research
  • Yunnan Provincial Science and Technology Department Social Development Special Project

Zitieren

APA

Lu, R., Zhang, J., Bao, G., Kong, Y., Xv, D., & Wang, S. (2026). Laminin Gamma 2 (LAMC2)-Targeting F(ab′) 2 for 89 Zr Immuno-PET Imaging of Human NSCLC Xenograft Models. Molecular Pharmaceutics, 23(7), 3732-3742. https://doi.org/10.1021/acs.molpharmaceut.6c00200

Vancouver

Lu R, Zhang J, Bao G, Kong Y, Xv D, Wang S. Laminin Gamma 2 (LAMC2)-Targeting F(ab′) 2 for 89 Zr Immuno-PET Imaging of Human NSCLC Xenograft Models. Molecular Pharmaceutics. 2026;23(7):3732-3742. doi:10.1021/acs.molpharmaceut.6c00200

BibTeX
@article{Lu2026,
  author = {Lu, RenCai and Zhang, JianFang and Bao, GuangFa and Kong, YanYan and Xv, DongDong and Wang, ShaoBo},
  title = {Laminin Gamma 2 (LAMC2)-Targeting F(ab′) 2 for 89 Zr Immuno-PET Imaging of Human NSCLC Xenograft Models},
  journal = {Molecular Pharmaceutics},
  year = {2026},
  volume = {23},
  number = {7},
  pages = {3732--3742},
  doi = {10.1021/acs.molpharmaceut.6c00200}
}
Kostenlos starten →